Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis.
Peter P TothCraig GranowitzMichael HullAmy AndersonSephy PhilipPublished in: Lipids in health and disease (2019)
Long-term statin persistence after 5 years is alarmingly low (< 25%) and is a public health concern.